>>Glycerophospho-N-Eicosapentaenoyl Ethanolamine

Glycerophospho-N-Eicosapentaenoyl Ethanolamine (Synonyms: GP-NEPEA)

Catalog No.GC43775

N-Acylated ethanolamines (NAEs) are naturally-occurring lipids that have diverse bioactivities.

Products are for research use only. Not for human use. We do not sell to patients.

Glycerophospho-N-Eicosapentaenoyl Ethanolamine Chemical Structure

Size 가격 재고 수량
1mg
US$114.00
재고 있음
5mg
US$518.00
재고 있음
10mg
US$918.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N-Acylated ethanolamines (NAEs) are naturally-occurring lipids that have diverse bioactivities. For example, arachidonoyl ethanolamide is an endogenous neurotransmitter that evokes cellular responses by activating the cannabinoid (CB) receptors, central CB1 and peripheral CB2. The different types of NAEs are derived from glycerophospho-linked precursors by the activity of glycerophosphodiesterase 1. Glycerophospho-N-eicosapentaenoyl ethanolamine is the metabolic precursor of eicosapentaenoyl ethanolamide . EPEA is an NAE that inhibits dietary-restriction-induced lifespan extension in wild type and TOR pathway mutant nematodes. EPEA also has anti-inflammatory properties, suppressing the expression of IL-6 and MCP-1 in 3T3-L1 adipocytes in response to lipopolysaccharide.

리뷰

Review for Glycerophospho-N-Eicosapentaenoyl Ethanolamine

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Glycerophospho-N-Eicosapentaenoyl Ethanolamine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.